Total Neoadjuvant Treatment With or Without Tislelizumab for Locally Advanced Rectal Cancer.

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(2 sites)

Germany

Johannes Gutenberg-University Clinic, Mainz, Germany 1.Dept. Medicine, Prof. Peter R. Galle, Mainz

Israel

Davidoff Cancer Center, Rabin Medical Center, Beilinson Hospital, Petah Tikva